NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/07/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,838.01 mln
Float60.36 mln
Earnings Date08/06/2026
1-Year Forecast
25.60
Transformational upside
Relative Strength
76
/ 100
Strongly outperforming
Debt / Equity
-0.11
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Payout Ratio
0%
No payout
Business Description
Generate Biomedicines is a biotechnology company based in Somerville, Massachusetts, that uses machine learning to design and develop new protein-based medicines. The company is advancing several drug candidates, including treatments targeting severe asthma, cancer, and other serious conditions. Its proprietary platform combines advanced computing with laboratory technology to create therapies that would be difficult or impossible to develop using conventional methods. Founded in 2018, the company aims to push the boundaries of what modern medicine can achieve.